{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:28:10Z","timestamp":1782278890993,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ando.2020.03.008","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T21:43:39Z","timestamp":1591393419000},"page":"167-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiac complications of thyroid hormone resistance syndromes"],"prefix":"10.1016","volume":"82","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Illouz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Briet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Mirebeau-Prunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Bouhours-Nouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Rodien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2020.03.008_bib0150","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/j.bbagen.2012.08.005","article-title":"The syndromes of reduced sensitivity to thyroid hormone","volume":"1830","author":"Dumitrescu","year":"2013","journal-title":"Biochim et Biophy Acta (BBA)"},{"key":"10.1016\/j.ando.2020.03.008_bib0155","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1210\/en.2017-00250","article-title":"Thyroid hormone signaling pathways: time for a more precise nomenclature","volume":"158","author":"Flamant","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2020.03.008_bib0160","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrendo.2014.143","article-title":"Thyroid hormone receptors and resistance to thyroid hormone disorders","volume":"10","author":"Ortiga-Carvalho","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2020.03.008_bib0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/jcem-27-2-279","article-title":"Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone","volume":"27","author":"Refetoff","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.008_bib0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa1110296","article-title":"A Mutation in the Thyroid Hormone Receptor Alpha Gene","volume":"366","author":"Bochukova","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2020.03.008_bib0175","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1210\/en.2003-0522","article-title":"Cardiac Expression and Function of Thyroid Hormone Receptor Beta and Its PV Mutant","volume":"144","author":"Swanson","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2020.03.008_bib0180","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.RES.86.6.700","article-title":"Cardiac dysfunction caused by myocardium-specific expression of a mutant thyroid hormone receptor","volume":"86","author":"Pazos-Moura","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.ando.2020.03.008_bib0185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/endo.140.2.6527","article-title":"Altered Cardiac Phenotype in Transgenic Mice Carrying the delta337 Threonine Thyroid Hormone Receptor Beta Mutant Derived From the S Family","volume":"140","author":"Gloss","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2020.03.008_bib0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physiolgenomics.00115.2015","article-title":"Thyroid hormone receptor-\u03b1 deletion decreases heart function and exercise performance in apolipoprotein E-deficient mice","volume":"48","author":"Liu","year":"2016","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.ando.2020.03.008_bib0195","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endoc Rev"},{"key":"10.1016\/j.ando.2020.03.008_bib0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ando.2020.03.008_bib0205","doi-asserted-by":"crossref","first-page":"E11323","DOI":"10.1073\/pnas.1706801115","article-title":"Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo","volume":"114","author":"H\u00f6nes","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2020.03.008_bib0210","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/0003-4819-123-8-199510150-00002","article-title":"Genetic and Clinical Features of 42 Kindreds with Resistance to Thyroid Hormone: The National Institutes of Health Prospective Study","volume":"123","author":"Brucker-Davis","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2020.03.008_bib0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.1994.4.225","article-title":"The Variable Clinical Phenotype in Thyroid Hormone Resistance Syndrome","volume":"4","author":"Beck-Peccoz","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2020.03.008_bib0220","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s40618-019-1007-4","article-title":"Thyroid hormone resistance from newborns to adults: a Spanish experience","volume":"42","author":"Vela","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2020.03.008_bib0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jcem.87.1.8170","article-title":"Cardiac Involvement in Thyroid Hormone Resistance","volume":"87","author":"Kahaly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.008_bib0230","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1210\/jc.2009-0096","article-title":"Impact of resistance to thyroid hormone on the cardiovascular system in adults","volume":"94","author":"Pulcrano","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.008_bib0235","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2017.02.029","article-title":"Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes","volume":"15","author":"Groeneweg","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2020.03.008_bib0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1990.tb00858.x","article-title":"Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D thyroxine: a study in three patients","volume":"32","author":"Dorey","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.03.008_bib0245","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2020.03.008_bib0250","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ihj.2017.07.004","article-title":"Atrial fibrillation and hyperthyroidism: a literature review","volume":"69","author":"Reddy","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ando.2020.03.008_bib0255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM198108273050906","article-title":"Hyperthyroidism and Mitral-Valve Prolapse","volume":"305","author":"Channick","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2020.03.008_bib0260","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/hrt.53.4.374","article-title":"Mitral valve prolapse in hyperthyroidism of two different origins","volume":"53","author":"Brauman","year":"1985","journal-title":"Br Heart J"},{"key":"10.1016\/j.ando.2020.03.008_bib0265","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMc1113940","article-title":"Clinical phenotype and mutant TR\u03b11","volume":"366","author":"Van Mullem","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2020.03.008_bib0270","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1210\/jc.2013-2215","article-title":"An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor \u03b1","volume":"98","author":"Moran","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.008_bib0275","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-8587(14)70111-1","article-title":"Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)\u03b11 and TR\u03b12: clinical, biochemical, and genetic analyses of three related patients","volume":"2","author":"Moran","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2020.03.008_bib0280","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1210\/jc.2016-1404","article-title":"Diverse Genotypes and Phenotypes of Three Novel Thyroid Hormone Receptor-\u03b1 Mutations","volume":"101","author":"Demir","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.008_bib0285","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz008","article-title":"Thyroid hormone transporters","volume":"41","author":"Groeneweg","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2020.03.008_bib0290","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S2213-8587(19)30155-X","article-title":"Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial","volume":"7","author":"Groeneweg","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:52:52Z","timestamp":1757717572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426620300433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":29,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0003426620300433"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2020.03.008","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac complications of thyroid hormone resistance syndromes","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2020.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}